Pharma BD Deal Intelligence

Pfizer Inc. / Capsugel (Pfizer divestiture to KKR)

2011 · Acquisition/Merger · $2.4B · Complete

Announcement Sentiment

Strongly positive

Pfizer announced April 5, 2011 the sale of Capsugel to KKR for ~$2.38B in cash; closed August 1, 2011. Capsugel is a leading pharma capsule and drug-delivery platform with ~$750M annual revenue.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Financial impact

Accretive

Assessment window: 10yr post-close.

Key facts

Announced Apr 21, 2011
Closed Aug 01, 2011
Deal value $2.4B
Deal type Acquisition/Merger
Therapeutic area Pharma drug delivery / dosage forms
Indications Pharma drug delivery / dosage forms
Key assets Hard-capsule manufacturing platform (180B+ capsules/yr)
Mechanism Hard gelatin/HPMC capsule technology and drug-delivery systems

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals